Published in Am J Psychiatry on May 17, 2010
Repetitive TMS & Cognitive Training in Adults With Schizophrenia (CrTMS) | NCT03741751
From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68
Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull (2011) 1.68
Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophr Bull (2011) 1.67
Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med (2014) 1.64
Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am J Psychiatry (2011) 1.47
Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry (2015) 1.44
Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull (2011) 1.38
Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behav Neurosci (2011) 1.20
Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry (2013) 1.15
The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology (2011) 1.15
Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry (2012) 1.12
Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord (2012) 1.08
Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr Res (2012) 1.01
Restoring large-scale brain networks in PTSD and related disorders: a proposal for neuroscientifically-informed treatment interventions. Eur J Psychotraumatol (2015) 1.00
Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res (2011) 1.00
Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disord (2012) 0.96
Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull (2011) 0.96
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry (2014) 0.96
Neuropsychological and socio-occupational functioning in young psychiatric outpatients: a longitudinal investigation. PLoS One (2013) 0.95
Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med (2012) 0.95
Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophr Res (2013) 0.95
Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings. J Psychiatr Res (2012) 0.93
Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation. Schizophr Res (2012) 0.92
Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophr Bull (2011) 0.91
Clinical applications of neuropsychological assessment. Dialogues Clin Neurosci (2012) 0.91
Social competence and observer-rated social functioning in bipolar disorder. Bipolar Disord (2010) 0.90
Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr Res (2011) 0.90
Mood symptoms, cognition, and everyday functioning: in major depression, bipolar disorder, and schizophrenia. Innov Clin Neurosci (2011) 0.89
Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation. Psychiatry Res (2013) 0.88
Technology, society, and mental illness: challenges and opportunities for assessment and treatment. Innov Clin Neurosci (2012) 0.88
Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disord (2014) 0.87
Biomarkers of bipolar disorder: specific or shared with schizophrenia? Front Biosci (Elite Ed) (2013) 0.86
Neurocognitive and functional correlates of mobile phone use in middle-aged and older patients with schizophrenia. Aging Ment Health (2015) 0.86
Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance. Schizophr Res Cogn (2014) 0.85
Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J Clin Psychiatry (2011) 0.85
The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan. Schizophr Bull (2014) 0.84
Determinants of occupational and residential functioning in bipolar disorder. J Affect Disord (2011) 0.84
Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.83
Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiol Dis (2012) 0.83
Affective symptoms and intra-individual variability in the short-term course of cognitive functioning in bipolar disorder. Psychol Med (2011) 0.83
Initial validation of a computerized version of the UCSD Performance-Based Skills Assessment (C-UPSA) for assessing functioning in schizophrenia. Schizophr Res (2013) 0.82
Top-down computerized cognitive remediation in schizophrenia: a case study of an individual with impairment in verbal fluency. Case Rep Psychiatry (2015) 0.82
Age as a predictor of cognitive decline in bipolar disorder. Am J Geriatr Psychiatry (2013) 0.81
Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness. Acta Psychiatr Scand (2015) 0.81
The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int J Geriatr Psychiatry (2013) 0.80
Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains? Neuropsychiatr Dis Treat (2015) 0.80
UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. Schizophr Res (2015) 0.80
Insight and subjective measures of quality of life in chronic schizophrenia. Schizophr Res Cogn (2015) 0.80
Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophr Res (2013) 0.79
Subjective cognitive complaints and functional disability in patients with borderline personality disorder and their nonaffected first-degree relatives. Can J Psychiatry (2014) 0.79
Social skills training and computer-assisted cognitive remediation in schizophrenia. Schizophr Res (2015) 0.79
Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort. Schizophr Bull (2012) 0.79
Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care. Neuropsychiatry (London) (2013) 0.78
Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis. Schizophr Res (2014) 0.78
Correlates of disability in depressed older adults with bipolar disorder. Cut Edge Psychiatry Pract (2013) 0.78
Everyday functional ability across different phases of bipolar disorder. Psychiatry Res (2013) 0.78
Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT (2014) 0.78
A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia. Schizophr Res Cogn (2014) 0.78
Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports. J Psychiatr Res (2014) 0.77
Impaired musical ability in people with schizophrenia. J Psychiatry Neurosci (2014) 0.77
Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophr Res (2013) 0.77
The Course and Correlates of Everyday Functioning in Schizophrenia. Schizophr Res Cogn (2014) 0.77
Predictors of current functioning and functional decline in schizophrenia. Schizophr Res (2017) 0.76
Relational memory in psychotic bipolar disorder. Bipolar Disord (2012) 0.76
Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary study. Cogn Neuropsychiatry (2015) 0.76
Assessing motivation orientations in schizophrenia: Scale development and validation. Psychiatry Res (2014) 0.76
Effect of obesity on cognition in adults with and without a mood disorder: study design and methods. BMJ Open (2016) 0.76
The Relationship Between Neurocognitive Functioning and Occupational Functioning in Bipolar Disorder: A Literature Review. Eur J Psychol (2016) 0.75
Longitudinal relations between symptoms, neurocognition, and self-concept in schizophrenia. Front Psychol (2015) 0.75
Disability among Attendees with Schizophrenia in a Nigerian Hospital: Further Evidence for Integrated Rehabilitative Treatment Designs. Ment Illn (2016) 0.75
Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders. Curr Behav Neurosci Rep (2016) 0.75
Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding. Schizophr Res (2015) 0.75
Coping strategies and real-world functioning in bipolar disorder. J Affect Disord (2016) 0.75
Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord (2017) 0.75
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand. Clinicoecon Outcomes Res (2016) 0.75
Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues. Psychiatr Clin North Am (2015) 0.75
Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies. Neuropsychology (2016) 0.75
The relationship between sleep quality and neurocognition in bipolar disorder. J Affect Disord (2015) 0.75
Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel Meeting. Popul Health Manag (2016) 0.75
Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder. J Psychiatr Res (2017) 0.75
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis. Eur Child Adolesc Psychiatry (2015) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry (1994) 11.85
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc (2004) 6.64
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65
The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res (1988) 2.61
Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry (2006) 2.42
Barriers to employment for people with schizophrenia. Am J Psychiatry (2006) 2.42
Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry (2002) 2.39
SLOF: a behavioral rating scale for assessing the mentally ill. Soc Work Res Abstr (1983) 2.37
Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry (2008) 2.35
The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord (2001) 2.32
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry (2005) 2.32
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology (1997) 2.19
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res (2009) 2.08
Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry (2006) 1.69
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord (2007) 1.65
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry (2009) 1.65
The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res (2004) 1.59
Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr Bull (2009) 1.54
A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin (2004) 1.52
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord (2008) 1.37
Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatr Serv (2004) 1.25
Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff". Schizophr Bull (2006) 1.23
Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects. Schizophr Res (2008) 1.23
Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects. Schizophr Res (2006) 1.19
Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am J Geriatr Psychiatry (2007) 1.19
Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J Clin Psychiatry (2007) 1.18
Assessing cognitive deficits in bipolar disorder: are self-reports valid? Psychiatry Res (2005) 1.16
An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord (2003) 1.14
Executive function and employment status among veterans with bipolar disorder. Psychiatr Serv (2007) 1.06
A relationship between neurocognitive impairment and functional impairment in bipolar disorder: a pilot study. Psychiatry Res (2007) 0.97
Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosci (2008) 0.93
Assessment of medication management ability in middle-aged and older adults with bipolar disorder. J Clin Psychopharmacol (2008) 0.92
Functional outcome and disability in bipolar disorders: ongoing research and future directions. Bipolar Disord (2007) 0.91
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet (2008) 6.42
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend (2007) 4.04
Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse (2006) 4.01
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol (2008) 3.72
Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend (2005) 3.67
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 3.57
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2008) 3.34
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr (2008) 3.14
Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat (2002) 3.13
Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J Urban Health (2006) 3.04
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry (2006) 2.95
Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med (2010) 2.82
Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse (2006) 2.81
Mobile interventions for severe mental illness: design and preliminary data from three approaches. J Nerv Ment Dis (2010) 2.80
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One (2008) 2.51
Characteristics of female sex workers with US clients in two Mexico-US border cities. Sex Transm Dis (2008) 2.48
Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull (2007) 2.47
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS (2007) 2.39
Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry (2002) 2.39
Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet (2010) 2.38
Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One (2011) 2.34
The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33
A qualitative exploration of female sex work in Tijuana, Mexico. Arch Sex Behav (2004) 2.31
The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol (2012) 2.28
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18
Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study. Drug Alcohol Depend (2006) 2.17
Assessing disability in older patients with schizophrenia: results from the WHODAS-II. J Nerv Ment Dis (2004) 2.12
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11
Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place (2009) 2.07
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One (2012) 2.02
Correlates of self-rated successful aging among community-dwelling older adults. Am J Geriatr Psychiatry (2006) 1.99
The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol (2007) 1.98
Direct assessment of functional abilities: relevance to persons with schizophrenia. Schizophr Res (2004) 1.97
Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol (2004) 1.95
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res (2006) 1.94
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res (2010) 1.91
[Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico]. Gac Med Mex (2009) 1.86
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet (2006) 1.84
Sleep in spousal caregivers of people with Alzheimer's disease. Sleep (2005) 1.83
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81
Female methamphetamine users: social characteristics and sexual risk behavior. Women Health (2004) 1.81
An exploration of contextual factors that influence HIV risk in female sex workers in Mexico: The Social Ecological Model applied to HIV risk behaviors. AIDS Care (2009) 1.80
Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry (2006) 1.80
A review of performance-based measures of functional living skills. J Psychiatr Res (2005) 1.73
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol (2003) 1.67
The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav (2004) 1.67
Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res (2009) 1.66
The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat (2011) 1.65
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry (2009) 1.65
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64
Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol (2005) 1.62
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med (2009) 1.59
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59
Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophr Res (2006) 1.58
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57
Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 1.57
Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol (2007) 1.57
A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend (2004) 1.57
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 1.55
Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res (2007) 1.55
Depression and distress predict time to cardiovascular disease in dementia caregivers. Health Psychol (2007) 1.55
Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr Bull (2009) 1.54
HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol (2011) 1.54
Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry (2012) 1.53
A comparison of registered and unregistered female sex workers in Tijuana, Mexico. Public Health Rep (2010) 1.53
Establishing an implementation network: lessons learned from community-based participatory research. Implement Sci (2009) 1.52
Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. Arch Gen Psychiatry (2008) 1.51
Association between higher levels of sexual function, activity, and satisfaction and self-rated successful aging in older postmenopausal women. J Am Geriatr Soc (2011) 1.50